World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland
Objectives To explore and reflect on the current anticoagulation therapy offered to patients with atrial fibrillation (AF), potential challenges and the future vision for oral anticoagulants for patients with AF and healthcare professionals in Ireland.Design A multistakeholder focus group using a Wo...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/9/e036493.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841553759681904640 |
|---|---|
| author | Colin Bradley Stephen McCarthy Aileen Murphy Stephen Brosnan Paidi O’Raghallaigh Ann Kirby |
| author_facet | Colin Bradley Stephen McCarthy Aileen Murphy Stephen Brosnan Paidi O’Raghallaigh Ann Kirby |
| author_sort | Colin Bradley |
| collection | DOAJ |
| description | Objectives To explore and reflect on the current anticoagulation therapy offered to patients with atrial fibrillation (AF), potential challenges and the future vision for oral anticoagulants for patients with AF and healthcare professionals in Ireland.Design A multistakeholder focus group using a World Café approach.Participants Nine participants from academic, clinical and health backgrounds attended the focus group together with a facilitator.Results Enhanced patient empowerment; more effective use of technology and developing system-based medical care pathways would provide improved supports for AF management. The challenges in providing these include cost and access issues, the doctor–patient relationship and the provision of education. While consensus for developing evidence-based pathways to maximise efficiency and effectiveness of AF treatment was evident, it would require a shared vision between stakeholders of integrated care. The benefits of embracing technological advances for clinicians and patients were evident; however, clinicians indicate this can increase pressure on already stretched resources; coupled with institutional barriers (including scarce resources) arising from the complex nature of anticoagulation for patients with AF, which emerged strongly. Including the unpredictable nature of warfarin, hidden costs associated with monitoring, adverse clinical effects, different patient cohorts (including those prescribed anticoagulant for the first time vs those switching from warfarin to a new oral anticoagulant (NOAC)), non-adherence concerns and undesirable impacts on patients’ daily lives.Conclusions While anticoagulation therapy for patients with AF using NOACs has been widely adopted and is diffusing into routine practice, significant operationalisation issues and barriers to effective treatment/management persist. The reflections reported in this study are a catalyst for future discussion and research. |
| format | Article |
| id | doaj-art-a397b9979ca44763b378d4f39a08f216 |
| institution | Kabale University |
| issn | 2044-6055 |
| language | English |
| publishDate | 2020-09-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-a397b9979ca44763b378d4f39a08f2162025-01-09T06:15:12ZengBMJ Publishing GroupBMJ Open2044-60552020-09-0110910.1136/bmjopen-2019-036493World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in IrelandColin Bradley0Stephen McCarthy1Aileen Murphy2Stephen Brosnan3Paidi O’Raghallaigh4Ann Kirby5Department of General Practice, University College Cork, Cork, IrelandDepartment of Nursing, Midwifery and Health, Northumbria University, Newcastle upon Tyne, UKDepartment of Economics, Cork University Business School, University College Cork, Cork, IrelandDepartment of Economics, Cork University Business School, University College Cork, Cork, IrelandINFANT Research Centre, University College Cork, Cork, IrelandDepartment of Economics, Cork University Business School, University College Cork, Cork, IrelandObjectives To explore and reflect on the current anticoagulation therapy offered to patients with atrial fibrillation (AF), potential challenges and the future vision for oral anticoagulants for patients with AF and healthcare professionals in Ireland.Design A multistakeholder focus group using a World Café approach.Participants Nine participants from academic, clinical and health backgrounds attended the focus group together with a facilitator.Results Enhanced patient empowerment; more effective use of technology and developing system-based medical care pathways would provide improved supports for AF management. The challenges in providing these include cost and access issues, the doctor–patient relationship and the provision of education. While consensus for developing evidence-based pathways to maximise efficiency and effectiveness of AF treatment was evident, it would require a shared vision between stakeholders of integrated care. The benefits of embracing technological advances for clinicians and patients were evident; however, clinicians indicate this can increase pressure on already stretched resources; coupled with institutional barriers (including scarce resources) arising from the complex nature of anticoagulation for patients with AF, which emerged strongly. Including the unpredictable nature of warfarin, hidden costs associated with monitoring, adverse clinical effects, different patient cohorts (including those prescribed anticoagulant for the first time vs those switching from warfarin to a new oral anticoagulant (NOAC)), non-adherence concerns and undesirable impacts on patients’ daily lives.Conclusions While anticoagulation therapy for patients with AF using NOACs has been widely adopted and is diffusing into routine practice, significant operationalisation issues and barriers to effective treatment/management persist. The reflections reported in this study are a catalyst for future discussion and research.https://bmjopen.bmj.com/content/10/9/e036493.full |
| spellingShingle | Colin Bradley Stephen McCarthy Aileen Murphy Stephen Brosnan Paidi O’Raghallaigh Ann Kirby World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland BMJ Open |
| title | World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland |
| title_full | World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland |
| title_fullStr | World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland |
| title_full_unstemmed | World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland |
| title_short | World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland |
| title_sort | world cafe approach exploring the future vision of oral anticoagulants for patients with atrial fibrillation af in ireland |
| url | https://bmjopen.bmj.com/content/10/9/e036493.full |
| work_keys_str_mv | AT colinbradley worldcafeapproachexploringthefuturevisionoforalanticoagulantsforpatientswithatrialfibrillationafinireland AT stephenmccarthy worldcafeapproachexploringthefuturevisionoforalanticoagulantsforpatientswithatrialfibrillationafinireland AT aileenmurphy worldcafeapproachexploringthefuturevisionoforalanticoagulantsforpatientswithatrialfibrillationafinireland AT stephenbrosnan worldcafeapproachexploringthefuturevisionoforalanticoagulantsforpatientswithatrialfibrillationafinireland AT paidioraghallaigh worldcafeapproachexploringthefuturevisionoforalanticoagulantsforpatientswithatrialfibrillationafinireland AT annkirby worldcafeapproachexploringthefuturevisionoforalanticoagulantsforpatientswithatrialfibrillationafinireland |